Health News
A photo of the opening ceremony of the 21st Annual Susan G. Komen Global Race for the Cure is available on Business Wire's Web Site and AP PhotoExpress.
19:37 Jun 6, 2010
Alli is a very popular weight loss supplement created by GlaxoSmithKline . Unlike so many weight loss products out there, Alli is FDA approved to help you lose weight. How does it work?
18:38 Jun 6, 2010
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO , were presented today during a poster discussion session at the 2010 American Society ...
15:59 Jun 6, 2010
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology . These data ...
13:15 Jun 6, 2010
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, both in Detroit, and the Children's Hospital of Michigan/Detroit Medical Center, presented preliminary data that identified a potential link ...
12:01 Jun 6, 2010
Incyte Corporation announced today additional positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 66 patients with HER2-positive metastatic breast cancer during a poster session ...
12:00 Jun 6, 2010
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today presented updated clinical data on CAL-101, the Company's oral,...
12:00 Jun 6, 2010
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 , an orally available small molecule inhibitor of phosphoinositide-3-kinase and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, ...
12:00 Jun 6, 2010
Santa Barbara Medical Innovations recently participated in the Microsoft Founder's Gala. This event is held in association with the Bill and Melinda Gates Foundation.
11:43 Jun 6, 2010
Vitiligo â€
10:20 Jun 6, 2010
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer. A total of 68 patients were enrolled with platinum-resistant disease, ...
09:31 Jun 6, 2010
A colorful stream of 2,400 bicyclists and volunteer "roadies" from nearly every state and eight countries left San Francisco this morning on the way to Los Angeles as participants in AIDS/LifeCycle, the world's largest annual HIV/AIDS ...
09:23 Jun 6, 2010
Results of a Phase III study presented today at the American Society of Clinical Oncology Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival compared with Treatment of Physician's Choice in heavily ...
08:00 Jun 6, 2010
Only five months after Mercy For Animals' undercover video at Willet Dairy aired on Nightline and inspired legislation to prevent future abuses, a new Mercy For Animals dairy video has even ag professionals crying uncle.
07:34 Jun 6, 2010
Amgen today announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer. The results are being presented for the first time in an oral ...
06:01 Jun 6, 2010
OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled ...
06:00 Jun 6, 2010
Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed ...
06:00 Jun 6, 2010
Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine , June 5-9, in ...
06:00 Jun 6, 2010
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense Injection plus chemotherapy in patients with advanced melanoma. The presentation included a 'pooled ...
05:10 Jun 6, 2010
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular ...
05:01 Jun 6, 2010
79798 - 79817 of 126305 Stories
<<
<
Next 20 Health News
>
>>
Search News
Daily News
